Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Thor Industries
THO
$4.13B
| $106M | 0.06% |
996,375
-78,338
| -7% | -$6.13M |
|
302
UBS Group
UBS
$171B
| $106M | 0.06% |
9,223,114
+7,374,577
| +399% | +$76M |
|
303
Intercontinental Exchange
ICE
$86.4B
| $106M | 0.06% |
1,155,317
-1,470,722
| -56% | -$135M |
|
304
F5
FFIV
$22.8B
| $105M | 0.06% |
754,698
+134,878
| +22% | +$18.2M |
|
|
ATVI
305
DELISTED
Activision Blizzard
ATVI
| $105M | 0.06% |
1,385,445
-2,681
| -0.2% | -$187K |
|
306
VeriSign
VRSN
$25.4B
| $105M | 0.06% |
507,952
+444,488
| +700% | +$92.3M |
|
307
GATX Corp
GATX
$6.6B
| $104M | 0.06% |
1,707,671
+85,486
| +5% | +$5.14M |
|
308
Donaldson
DCI
$11.1B
| $104M | 0.06% |
2,233,228
-259,785
| -10% | -$11.5M |
|
309
Williams-Sonoma
WSM
$27.8B
| $103M | 0.06% |
2,523,004
-3,965,484
| -61% | -$135M |
|
310
NewMarket
NEU
$7.2B
| $103M | 0.06% |
257,273
-68,604
| -21% | -$28.3M |
|
311
Hartford Financial Services
HIG
$39.3B
| $102M | 0.06% |
2,655,721
-613,666
| -19% | -$23.4M |
|
312
Hanover Insurance
THG
$7.84B
| $102M | 0.06% |
1,008,088
+61,075
| +6% | +$5.99M |
|
313
EnerSys
ENS
$6.69B
| $102M | 0.06% |
1,580,606
-298,683
| -16% | -$17.6M |
|
314
LiveRamp
RAMP
$2.29B
| $102M | 0.06% |
2,394,986
+591,655
| +33% | +$23.3M |
|
|
ALTR
315
DELISTED
Altair Engineering Inc
ALTR
| $101M | 0.06% |
2,547,068
+57,433
| +2% | +$1.95M |
|
316
Unifirst Corp
UNF
$5.43B
| $99.6M | 0.06% |
556,662
-30,409
| -5% | -$5.09M |
|
317
WaFd
WAFD
$2.71B
| $98.9M | 0.06% |
3,685,738
+582,297
| +19% | +$15M |
|
318
Rhythm Pharmaceuticals
RYTM
$7.41B
| $98.4M | 0.06% |
4,410,488
+91,455
| +2% | +$1.78M |
|
319
CDW
CDW
$18.4B
| $97.8M | 0.05% |
841,059
-354,226
| -30% | -$38.4M |
|
320
Southwest Gas
SWX
$6.7B
| $97.6M | 0.05% |
1,413,957
+32,011
| +2% | +$2.33M |
|
321
McCormick & Company Non-Voting
MKC
$13.9B
| $97.4M | 0.05% |
1,086,062
-225,262
| -17% | -$18.6M |
|
322
Ball Corp
BALL
$17.8B
| $96.6M | 0.05% |
1,389,676
+12,477
| +0.9% | +$843K |
|
323
Edison International
EIX
$30.7B
| $96.3M | 0.05% |
1,773,296
-220,395
| -11% | -$12.7M |
|
324
Alarm.com
ALRM
$2.7B
| $96.2M | 0.05% |
1,483,605
+163,720
| +12% | +$8.24M |
|
325
Jazz Pharmaceuticals
JAZZ
$16.1B
| $96.1M | 0.05% |
870,804
+44,819
| +5% | +$4.96M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.